HBIO

News Harvard Bioscience Tops Q2 Revenue Views

14d ago

News Harvard Bioscience reaffirms 2026 outlook for 2%-4% revenue growth as Project Viking targets $4M annual savings

21d ago

News Harvard Bioscience misses top-line and bottom-line estimates; initiates Q2 and reaffirms FY26 outlook

21d ago

Insider trade Purchase by Stephen J Denelsky

75d ago

Insider trade Purchase by John D Duke (Chief Executive Officer)

76d ago

SEC filing HBIO Announces $87M FY25 Revenue, $8M Adjusted EBITDA, 58% Gross Margin, 54% Adjusted EBITDA Margin, 10K+ Customers, $3M EBITDA Savings from Plant Closure, $7.5M Convertible Note Investment, New CEO John Duke, Expanded Board, Focus on Translational Science, Guides 58-60% FY26 Rev

77d ago

News Harvard Bioscience outlines 2026 guidance with 2%–4% revenue growth and high-margin focus following structural improvements

82d ago

SEC filing HBIO Announces $120M Share Repurchase Program, $45M Dividend, +15% YoY Revenue Growth

87d ago

News Harvard Cuts Bitcoin ETF Stake, Adds Ethereum Exposure in Q4 Filing

105d ago

News Harvard University's Investment Manager Loads Up On 3.87M ETHA Shares

106d ago

SEC filing HBIO Reports $23.7M Q4 Revenue, 60% Gross Margin, +27% Adjusted EBITDA; Outlines Strategy for Translational Science Growth

112d ago

News Trump says he is seeking $1bn in damages in Harvard dispute

119d ago

News Trump seeks $1 billion from Harvard University in damages

119d ago

News Trump says seeking US$1 billion from Harvard in ‘damages’

119d ago

News Trump seeks $1bn in damages from Harvard

119d ago

SEC filing Costs Associated with Exit or Disposal Activities

123d ago

News "It's Going To Get Really Serious": Liberal Influencers Discuss Public Trials, Court Expansion After Democratic Takeover

131d ago

News Harvard Division of Continuing Education Launches Harvard Ideas Symposium, Featuring Leading Harvard Faculty Across the Arts, Humanities, Sciences, and Law

131d ago

News Doseology Begins Pilot Production of Caffeine-Based Energy Pouches as Feed That Brain® Enters Oral Stimulant Format

132d ago

News Gopinath Points to Danger of a US Inflation Comeback in 2026

133d ago

News Doseology Files Annual Information Form (AIF), Strengthening Public Disclosure Record AIF Filing Enhances Transparency and Provides Consolidated Disclosure for Investors

136d ago

News Oxford Biomedica x It’s in Talks Over Cash Offer From EQT

138d ago

News Aptose Reports Third Quarter 2025 Results

155d ago

Scanner Unusual volume (z=4.7)

165d ago

News Replicate Bioscience Appoints Kathy Fernando, Ph.D., as Chief Business Officer

168d ago